Latest Novavax Inc. Stories

2014-06-10 12:32:11

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Novavax, Inc. - Product Pipeline Review - 2014http://www.reportbuyer.com/pharma_healthcare/therapeutic/novavax_inc_product_pipeline_review_2013.html Novavax, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Direct's, 'Novavax, Inc. - Product Pipeline Review - 2014', provides an overview of the Novavax, Inc.'s pharmaceutical research and development focus.This report provides...

2014-05-20 12:21:42

Editor Note: For more information about this release, please scroll to bottom LONDON, May 20, 2014 /PRNewswire/ -- The US markets saw a positive sentiment on Monday, May 19, 2014, with the NASDAQ Composite closing at 4,125.82, up 0.86%, the Dow Jones Industrial Average ending the session 0.12% higher at 16,511.86, and the S&P 500 edging 0.38% higher to finish the trading session at 1,885.08. During the session gains in the Information Technology, Health Care, and Financials...

2011-05-13 10:42:00

ROCKVILLE, Md., May 13, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Frederick Driscoll, Chief Financial Officer of Novavax, will be presenting at the NOBLE FINANCIAL 7th Annual Equity Conference on May 16, 2011 at 10:30am at The Hard Rock Hotel, Hollywood, FL. A live audio-only webcast link for the presentation can be accessed via the Company website at www.novavax.com under Investors/Events. About Novavax Novavax, Inc....

2011-05-11 08:03:00

ROCKVILLE, Md., May 11, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has been named Biotechnology Firm of the Year by the Tech Council of Maryland (TCM), the largest technology trade group serving the advanced technology and biotechnology communities of Maryland. Novavax was recognized as the firm that best exemplifies the spirit of the Maryland biotechnology community and for its presence and leadership in Maryland. The criteria for selection as biotechnology firm of the year...

2011-05-09 07:00:00

ROCKVILLE, Md., May 9, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results for the first quarter ended March 31, 2011. The company reported a net loss of $7.5 million, or $0.07 per share, for the first quarter of 2011, compared to a net loss of $10.3 million, or $0.10 per share, for the first quarter of 2010. The primary reason for the decreased loss during the quarter was due to lower research and development spending to support clinical trials of the...

Word of the Day
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.